Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Condition:   Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma) Intervention:   Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials